ABG Sundal Collier - Commissioned research

Latest commissioned research from ABG Sundal Collier

Bredband2 - Growth investments to taper off in H2e

Proact - Q1 beat but soft near-term outlook

Eolus Vind - Q1e: all about Pome

Read earlier research

Recent media selection from our coverage

Freemelt - Company presentation with CEO Daniel Gidlund

Prevas - Company presentation with President & CEO Magnus Welén

Clavister - Fireside chat with President & CEO John Vestberg

Clavister - Company presentation with President & CEO John Vestberg

Embellence Group - Company presentation with CEO Olle Svensk

Next event

Investor Days
13-14 May

Hotel At Six
Brunkebergstorg 6, Stockholm
(Registration is required)

CLICK HERE TO REGISTER

This event will also be
livestreamed at cr.abgsc.com
(No registration required)

CLICK TO VIEW PROGRAMME

Confirmed companies:

ABG Sundal Collier	Infrea
Acast	INVISIO
Alligo	Kameo
Ascelia Pharma	Lumi Gruppen
Astor Group	Medicover
B3 Consulting Group	Midsona
Berner Industrier	Nexam Chemical
Bredband2	Nilörn
Byggmästaren	Orexo
Cedergrenska	OrganoClick
Cereno Scientific	OssDsign
Clavister	Ovzon
CoinShares	Proact
Coor	Qliro
CTT Systems	Railcare
Eltel	Spiltan Invest
Embellence Group	Stendörren
Eolus Vind	StrongPoint
EQL Pharma	Studsvik
Freemelt	Svedbergs Group
Freja eID	Unibap
G5 Entertainment	Verve Group
Gentoo Media	Vestum
GLG	Viscaria
Humble Group

Latest company news

New company at ABGSC - Ascelia Pharma

About ABGSC

Enabling businesses and capital to grow and perform ABG Sundal Collier is founded on an inclusive partnership culture and the ability to attract and develop top talent. The merger between Norwegian Sundal Collier and Swedish ABG in 2001 laid the foundation for today’s independent, full-service investment bank. We have a strong Nordic heritage, with operations in Norway, Sweden and Denmark and a global reach through our sales offices in Frankfurt, London, New York and Singapore. Relying on our superior transaction experience and network, we advise and guide clients when acquiring, consolidating or selling assets. With our outstanding investor access and placing power, we help corporations and entrepreneurs to finance their businesses. Through our highquality research, we enable smarter investment decisions. We are committed to excellence, and offer deep sector knowledge, extensive transaction experience and access to a large network of corporates and investors. We take great pride in always delivering first-class service, and we always seek to obtain a high degree of client satisfaction.

Past event

Investor Days
4-5 December

This seminar was recorded
at Hotel At Six in Stockholm

CLICK BELOW TO VIEW
COMPANY PRESENTATIONS

A3P	INVISIO
ABG Private Banking	IRLAB Therapeutics
Arctic Paper	I-tech
B3 Consulting Group	Midsona
Bredband2	Nexam Chemicals
BTS Group	Nordisk Bergteknik
Byggmästaren	OrganoClick
Careium	OssDsign
Cereno Scientific	Ovzon
Cinis Fertilizer	Prevas
Clavister	Pricer
CoinShares	Proact
Eastnine	Rottneros
Eltel	SinterCast
Embellence Group	Skolon
Embla Medical	Stendörren
Energy Save	Stenhus Fastigheter
Eolus Vind	StrongPoint
Ework Group	Svedbergs Group
Ferronordic	Tempest Security
Freemelt	Verve Group
G5 Entertainment	Vestum
GLG	Vitrolife
Inission	Xplora Technologies

Press the button and be introduced to a new random company!

Social media

Latest commissioned research from ABG Sundal Collier

Bredband2 - Growth investments to taper off in H2e

Proact - Q1 beat but soft near-term outlook

Eolus Vind - Q1e: all about Pome

Recent media selection from our coverage

ABGSC Investor Days 13-14 May

New company at ABGSC - Ascelia Pharma

SinterCast

SinterCast - Fireside chat with CEO Steve Dawson

Nexam Chemical

Nexam Chemical - Fireside chat with CEO Ronnie Törnqvist

Skolon

Skolon - Fireside chat with CEO Oliver Lundgren